The molecular biology of neuroendocrine cervical carcinoma: Are we witnessing early or late events?

被引：8

作者：

Crum, CP

机构：

[1] Brigham & Womens Hosp, Div Womens & Perinatal Pathol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

GYNECOLOGIC ONCOLOGY | 1999年 / 72卷 / 01期

关键词：

D O I：

10.1006/gyno.1998.5313

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1 / 2

页数：2

共 15 条

[1]

AlboresSaavedra J, 1997, ARCH PATHOL LAB MED, V121, P34

[2]

CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO

[3]

2-B

[4]

Adenoid basal carcinoma of the uterine cervix, detection of integrated human papillomavirus in a rare tumor of putative "reserve cell" origin [J].

Grayson, W ;

Taylor, LF ;

Cooper, K .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1997, 16 (04) :307-312

[5]

Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma [J].

Kim, JW ;

Cho, YH ;

Lee, CG ;

Kim, JH ;

Kim, HK ;

Kim, EJ ;

Han, KT ;

Namkoong, SE .

ACTA ONCOLOGICA, 1997, 36 (03) :295-300

[6]

Larson AA, 1997, CANCER RES, V57, P4082

[7]

Le Beau MM, 1998, GENE CHROMOSOME CANC, V21, P281, DOI 10.1002/(SICI)1098-2264(199804)21:4<281::AID-GCC1>3.0.CO

[8]

2-V

[9]

MCLACHLIN CM, 1994, AM J PATHOL, V144, P141

[10]

Minna John D., 1997, P849

← 1 2 →